Posted by Admin | Posted in Medical Lawyers | Posted on 27-02-2010
CHANDLER, Ariz. (EGMN) Nearly a third of patients with laryngeal cancer who underwent therapy that was designed to preserve their larynx were still alive and cancer free with an intact and functioning larynx 5 years later, French researchers report.
Posted by Admin | Posted in Medical Lawyers | Posted on 26-02-2010
A multisite randomized controlled trial comparing carotid endarterectomy with implantation of a carotid artery stent has shown the more invasive surgical procedure to be the safer and more effective at least in the short term.
Posted by Admin | Posted in Medical Lawyers | Posted on 24-02-2010
SILVER SPRING, Md. (EGMN) A Food and Drug Administration advisory panel on Feb. 23 voted 14 to 4 that the risk-benefit profile of the oral antibiotic rifaximin supported its approval as a treatment to reduce the risk of developing episodes of overt hepatic encephalopathy in adults with chronic liver disease.
Posted by Admin | Posted in Medical Lawyers | Posted on 21-02-2010
Information about potential risks of renal impairment, renal failure, hepatic impairment, hepatic failure, and gastrointestinal hemorrhage appear in a boxed warning that was added to the prescribing information of the iron chelating agent deferasirox in January.
Posted by Admin | Posted in Medical Lawyers | Posted on 20-02-2010
A story titled FDA Requires Risk Management Plan for Erythropoiesis-Stimulating Agents (published Feb. 17, 2010) misstated the deadline date for clinicians toenroll in a certification program monitored by Amgen Inc. That date isFeb. 16, 2011.
Posted by Admin | Posted in Medical Lawyers | Posted on 19-02-2010
The Food and Drug Administration is requiring major changes to the prescribing information of inhaled long-acting beta agonists as part of a risk management plan to address the ongoing safety issues associated with the products use in children and adults with asthma, the agency announced at a Feb. 18 press briefing.
Posted by Admin | Posted in Medical Lawyers | Posted on 18-02-2010
Combination treatment with benazepril plus amlodipine reduces the progression of chronic kidney disease better than benazepril plus hydrochlorothiazide, according to a new analysis of data from a large randomized controlled trial published online Feb. 18 in The Lancet.
Posted by Admin | Posted in Medical Lawyers | Posted on 17-02-2010
Older patients and those having specific surgical procedures are more likely to experience never events even if health care providers adhere unerringly to best practices, a study published Feb. 15 in the Archives of Surgery found.